HENDERSON, Nev., Jan. 20, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the appointment of two new centralized laboratory ...
Since the beta launch of Nu.Q Vet Cancer Screening Test in late-November 2020, management has been in active discussions with a range of companies in the veterinarian products and services space in ...
In addition, the Volition team is hosting a meet and greet at exhibition booth #2943 showcasing the Company's Nu.Q ® Vet Cancer Test. Tom Butera, Chief Executive Officer of Volition Veterinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results